Cargando…
A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies
Lung cancer is one of the most common cancers in the population and is characterized by non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological treatment. Due to the difficult placement of the tumor, one of the main methods of lung cancer treatment is radiotherapy,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342525/ https://www.ncbi.nlm.nih.gov/pubmed/37446385 http://dx.doi.org/10.3390/ijms241311206 |
_version_ | 1785072519772897280 |
---|---|
author | Nowak, Paulina Bil-Lula, Iwona Śliwińska-Mossoń, Mariola |
author_facet | Nowak, Paulina Bil-Lula, Iwona Śliwińska-Mossoń, Mariola |
author_sort | Nowak, Paulina |
collection | PubMed |
description | Lung cancer is one of the most common cancers in the population and is characterized by non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological treatment. Due to the difficult placement of the tumor, one of the main methods of lung cancer treatment is radiotherapy, which damages the DNA of cancer cells, inducing their apoptosis. However, resistance to ionizing radiation may develop during radiotherapy cycles, leading to an increase in the number of DNA points of control that protect cells from apoptosis. Cancer stem cells are essential for radioresistance, and due to their ability to undergo epithelial–mesenchymal transition, they modify the phenotype, bypassing the genotoxic effect of radiotherapy. It is therefore necessary to search for new methods that could improve the cytotoxic effect of cells through new mechanisms of action. Chinese medicine, with several thousand years of tradition, offers a wide range of possibilities in the search for compounds that could be used in conventional medicine. This review introduces the potential candidates that may present a radiosensitizing effect on lung cancer cells, breaking their radioresistance. Additionally, it includes candidates taken from conventional medicine—drugs commonly available in pharmacies, which may also be significant candidates. |
format | Online Article Text |
id | pubmed-10342525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103425252023-07-14 A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies Nowak, Paulina Bil-Lula, Iwona Śliwińska-Mossoń, Mariola Int J Mol Sci Review Lung cancer is one of the most common cancers in the population and is characterized by non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological treatment. Due to the difficult placement of the tumor, one of the main methods of lung cancer treatment is radiotherapy, which damages the DNA of cancer cells, inducing their apoptosis. However, resistance to ionizing radiation may develop during radiotherapy cycles, leading to an increase in the number of DNA points of control that protect cells from apoptosis. Cancer stem cells are essential for radioresistance, and due to their ability to undergo epithelial–mesenchymal transition, they modify the phenotype, bypassing the genotoxic effect of radiotherapy. It is therefore necessary to search for new methods that could improve the cytotoxic effect of cells through new mechanisms of action. Chinese medicine, with several thousand years of tradition, offers a wide range of possibilities in the search for compounds that could be used in conventional medicine. This review introduces the potential candidates that may present a radiosensitizing effect on lung cancer cells, breaking their radioresistance. Additionally, it includes candidates taken from conventional medicine—drugs commonly available in pharmacies, which may also be significant candidates. MDPI 2023-07-07 /pmc/articles/PMC10342525/ /pubmed/37446385 http://dx.doi.org/10.3390/ijms241311206 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Nowak, Paulina Bil-Lula, Iwona Śliwińska-Mossoń, Mariola A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies |
title | A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies |
title_full | A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies |
title_fullStr | A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies |
title_full_unstemmed | A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies |
title_short | A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies |
title_sort | cross-talk about radioresistance in lung cancer—how to improve radiosensitivity according to chinese medicine and medicaments that commonly occur in pharmacies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342525/ https://www.ncbi.nlm.nih.gov/pubmed/37446385 http://dx.doi.org/10.3390/ijms241311206 |
work_keys_str_mv | AT nowakpaulina acrosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies AT billulaiwona acrosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies AT sliwinskamossonmariola acrosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies AT nowakpaulina crosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies AT billulaiwona crosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies AT sliwinskamossonmariola crosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies |